Deadline extended to apply for MERSCOPE® Platform Grant Program in partnership with Vizgen

The deadline for our MERSCOPE® Platform Grant Program, in collaboration with Vizgen, has been extended.

This extension offers researchers across Europe a valuable chance to leverage spatial transcriptomics in their field of research, for patient care and precision medicine enhancement.

The MERSCOPE® Platform Grant Program empowers you with exclusive access to Vizgen’s Predesigned panels (PanNeuro Cell Type, PanCancer Pathways, Immuno-Oncology) for the MERSCOPE® Platform in our labs to conduct a single-cell spatial analysis project that will enable you to drive your research forward. This invaluable opportunity is further enriched by access to an expert data analysis consultation, ensuring that you obtain extensive omic data and deep insights from your tissue samples.

For researchers in Europe eager to leverage state-of-the-art spatial transcriptomics services and technology, this Grant Program is tailor-made for you. You can win a 2-slide (FFPE) or 4-slide (FF) run of Vizgen’s Predesigned 500-gene panels for the MERSCOPE® Platform, provided by our genomics experts in our labs.

Whether you’re investigating molecular underpinnings of disease, identifying novel therapeutic targets, or personalizing treatment strategies, spatial transcriptomics holds the key to revealing new insights and enhancing patient care.

Don’t miss out on this opportunity, submit a short abstract (< 300 words) outlining your project’s objectives, methodologies, and anticipated outcomes and describing how you’d use the MERSCOPE® Platform. (Grant Application Page)

Submissions are open until June 30th. The winner will be notified in September 2024.